Share Twitter LinkedIn Facebook Email Leonard Saltz, MD, Executive Director for Clinical Value and Sustainability, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center addresses whether current data will change the way we treat colorectal cancer.
NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024 Colorectal 4 Mins Read
KRYSTAL-1: Adagrasib + Cetuximab Promise for KRASG12C Colorectal Cancer – Scott Kopetz, MD [AACR 2024] Colorectal 3 Mins Read
2024 Optimistic Advances in Colorectal Cancer: New Genetic Discoveries & Dancing Colorectal 5 Mins Read